Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ilunocitinib is a non-selective and orally active Janus kinase (JAK) inhibitor for the control of pruritus and atopic dermatitis caused by atopic dermatitis in dogs.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $116 | In Stock | |
5 mg | $257 | In Stock | |
10 mg | $398 | In Stock | |
25 mg | $813 | In Stock | |
50 mg | $1,320 | In Stock | |
100 mg | $1,990 | In Stock | |
200 mg | $2,980 | In Stock | |
1 mL x 10 mM (in DMSO) | $295 | In Stock |
Description | Ilunocitinib is a non-selective and orally active Janus kinase (JAK) inhibitor for the control of pruritus and atopic dermatitis caused by atopic dermatitis in dogs. |
In vivo | In a canine atopic dermatitis model, Ilunocitinib (0.6–0.8 mg/kg, oral, once daily, up to 112 days) significantly alleviated pruritus and skin lesions, showing superior efficacy over Oclacitinib from Day 28 onward, with good tolerability[1]. |
Alias | LY-3411067, LY3411067 |
Molecular Weight | 383.43 |
Formula | C17H17N7O2S |
Cas No. | 1187594-14-4 |
Smiles | N#CCC1(N2N=CC(=C2)C=3N=CN=C4NC=CC43)CN(C1)S(=O)(=O)C5CC5 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (521.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.